The role of astrocytes in multiple sclerosis pathogenesis

Noseworthy, 2000, Multiple sclerosis, N Engl J Med, 343, 938, 10.1056/NEJM200009283431307 Bruck, 2005, The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage, J Neurol, 252, v3, 10.1007/s00415-005-5002-7 Lassmann, 2014, Multiple sclerosis: lessons from molecular neuropathology, Exp Neurol, 262, 2, 10.1016/j.expneurol.2013.12.003 Disanto, 2010, Heterogeneity in multiple sclerosis: scratching the surface of a complex disease, Autoimmune Dis, 2011 Guerrero-Garcia, 2016, Multiple sclerosis and obesity: possible roles of adipokines, Mediators Inflamm, 2016, 10.1155/2016/4036232 Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann Neurol, 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q Sospedra, 2005, Immunology of multiple sclerosis, Annu Rev Immunol, 23, 683, 10.1146/annurev.immunol.23.021704.115707 Steinman, 2014, Immunology of relapse and remission in multiple sclerosis, Annu Rev Immunol, 32, 257, 10.1146/annurev-immunol-032713-120227 He, 2007, Glial cells more than support cells?, Int J Biochem Cell Biol, 39, 661, 10.1016/j.biocel.2006.10.022 Correale, 2015, The role of astrocytes in multiple sclerosis progression, Front Neurol, 6, 180, 10.3389/fneur.2015.00180 Moore, 2011, How factors secreted from astrocytes impact myelin repair, J Neurosci Res, 89, 13, 10.1002/jnr.22482 Farina, 2007, Astrocytes are active players in cerebral innate immunity, Trends Immunol, 28, 138, 10.1016/j.it.2007.01.005 Echchannaoui, 2002, Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation, J Infect Dis, 186, 798, 10.1086/342845 Shen, 2010, Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages, Infect Immun, 78, 2857, 10.1128/IAI.01138-09 Kurt-Jones, 2004, Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis, Proc Natl Acad Sci U S A, 101, 1315, 10.1073/pnas.0308057100 Poteet, 2016, Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV, Vaccine, 34, 5886, 10.1016/j.vaccine.2016.10.036 Prinz, 2006, Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis, J Clin Invest, 116, 456, 10.1172/JCI26078 Chattopadhyay, 2014, dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects, J Interferon Cytokine Res, 34, 427, 10.1089/jir.2014.0034 Kawai, 2007, Antiviral signaling through pattern recognition receptors, J Biochem, 141, 137, 10.1093/jb/mvm032 Bsibsi, 2006, Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators, Glia, 53, 688, 10.1002/glia.20328 Farina, 2005, Preferential expression and function of Toll-like receptor 3 in human astrocytes, J Neuroimmunol., 159, 12, 10.1016/j.jneuroim.2004.09.009 Andersson, 2008, Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis, J Leukoc Biol, 84, 1248, 10.1189/jlb.1207844 Crowley, 2015, Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis, Front Cell Neurosci, 9, 284, 10.3389/fncel.2015.00284 Chastain, 2011, The role of antigen presenting cells in multiple sclerosis, Biochim Biophys Acta, 1812, 265, 10.1016/j.bbadis.2010.07.008 Sofroniew, 2015, Astrocyte barriers to neurotoxic inflammation, Nat Rev Neurosci, 16, 249, 10.1038/nrn3898 Massa, 1993, Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons, Glia, 8, 201, 10.1002/glia.440080307 Gresser, 2000, Tumor necrosis factor alpha and interleukin-1 alpha inhibit through different pathways interferon-gamma-induced antigen presentation, processing and MHC class II surface expression on astrocytes, but not on microglia, Cell Tissue Res, 300, 373, 10.1007/s004410000222 Hamo, 2007, Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis, Glia, 55, 1169, 10.1002/glia.20538 Vidovic, 1990, Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha, J Neuroimmunol, 30, 189, 10.1016/0165-5728(90)90103-T Zeinstra, 2003, Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2, J Neuroimmunol, 135, 166, 10.1016/S0165-5728(02)00462-9 Soos, 1999, Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production, Int Immunol, 11, 1169, 10.1093/intimm/11.7.1169 Cross, 2000, Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis, J Neuroimmunol, 110, 76, 10.1016/S0165-5728(00)00327-1 Satoh, 1995, T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture, Brain Res, 704, 92, 10.1016/0006-8993(95)01177-3 Liu, 1989, Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro, J Neuroimmunol, 21, 157, 10.1016/0165-5728(89)90171-9 Hirayama, 1988, Infection of human T-lymphotropic virus type I to astrocytes in vitro with induction of the class II major histocompatibility complex, Neurosci Lett, 92, 34, 10.1016/0304-3940(88)90738-0 Vardjan, 2012, IFN-gamma-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments, J Neuroinflamm, 9, 144, 10.1186/1742-2094-9-144 Jarosinski, 2002, Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes, J Neuroimmunol, 122, 74, 10.1016/S0165-5728(01)00467-2 Morga, 1996, Interleukin-4 down-regulates MHC class II antigens on cultured rat astrocytes, Glia, 17, 175, 10.1002/(SICI)1098-1136(199606)17:2<175::AID-GLIA9>3.0.CO;2-1 Ransohoff, 1991, Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy, Arch Neurol, 48, 1244, 10.1001/archneur.1991.00530240048017 Frank, 1986, Expression of class II major histocompatibility antigens on reactive astrocytes and endothelial cells within the gliosis surrounding metastases and abscesses, J Neuroimmunol, 12, 29, 10.1016/0165-5728(86)90094-9 Zeinstra, 2000, Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules, Neuroreport, 11, 89, 10.1097/00001756-200001170-00018 Hirayama, 1986, Induction of human leukocyte antigen-A,B,C and -DR on cultured human oligodendrocytes and astrocytes by human gamma-interferon, Neurosci Lett, 72, 369, 10.1016/0304-3940(86)90543-4 Pulver, 1987, Cultured human fetal astrocytes can be induced by interferon-gamma to express HLA-DR, J Neuroimmunol, 14, 123, 10.1016/0165-5728(87)90047-6 Panek, 1994, Characterization of astrocyte nuclear proteins involved in IFN-gamma- and TNF-alpha-mediated class II MHC gene expression, J Immunol, 153, 4555, 10.4049/jimmunol.153.10.4555 Barna, 1989, Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes, J Neuroimmunol, 23, 45, 10.1016/0165-5728(89)90072-6 Satoh, 1995, Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes, Neurology, 45, 367, 10.1212/WNL.45.2.367 Kurtuncu, 2012, Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: significant modulation of IL-17 and IL-23, Cytokine, 59, 400, 10.1016/j.cyto.2012.05.004 Dressel, 2006, Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis, Acta Neurol Scand, 114, 368, 10.1111/j.1600-0404.2006.00700.x Khademi, 2000, Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis, J Neuroimmunol, 103, 202, 10.1016/S0165-5728(99)00184-8 Loma, 2011, Multiple sclerosis: pathogenesis and treatment, Curr Neuropharmacol, 9, 409, 10.2174/157015911796557911 Schluesener, 1990, Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha, J Neuroimmunol, 27, 41, 10.1016/0165-5728(90)90134-9 Lee, 1997, TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression, J Immunol, 158, 2065, 10.4049/jimmunol.158.5.2065 Czarniecki, 1988, Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells, J Immunol, 140, 4217, 10.4049/jimmunol.140.12.4217 Reimold, 1993, Transforming growth factor beta 1 repression of the HLA-DR alpha gene is mediated by conserved proximal promoter elements, J Immunol, 151, 4173, 10.4049/jimmunol.151.8.4173 Dong, 2001, The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression, J Immunol, 167, 311, 10.4049/jimmunol.167.1.311 Stuve, 2002, The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease, J Immunol, 169, 6720, 10.4049/jimmunol.169.12.6720 Lee, 1992, Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia, J Immunol, 148, 3391, 10.4049/jimmunol.148.11.3391 Frohman, 1988, Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes, J Neuroimmunol, 17, 89, 10.1016/0165-5728(88)90017-3 Massa, 1993, Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides, J Exp Med, 178, 1357, 10.1084/jem.178.4.1357 Massa, 1996, Modulation of major histocompatibility complex class I genes by interferon-gamma and ganglioside GT 1b in astrocytes: involvement of protein tyrosine phosphatases, J Neurochem, 67, 1831, 10.1046/j.1471-4159.1996.67051831.x Abdouh, 2001, Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes, J Biol Chem, 276, 4382, 10.1074/jbc.M004559200 Sternberg, 1986, Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists, J Immunol, 137, 276, 10.4049/jimmunol.137.1.276 Zeinstra, 2006, 5HT4 agonists inhibit interferon-gamma-induced MHC class II and B7 costimulatory molecules expression on cultured astrocytes, J Neuroimmunol, 179, 191, 10.1016/j.jneuroim.2006.06.012 Seddighzadeh, 2010, Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis, Eur J Hum Genet, 18, 821, 10.1038/ejhg.2010.12 Kostic, 2017, IL-17 signalling in astrocytes promotes glutamate excitotoxicity: Indications for the link between inflammatory and neurodegenerative events in multiple sclerosis, Mult Scler Relat Disord, 11, 12, 10.1016/j.msard.2016.11.006 Karki, 2014, Astrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-alpha in estrogen-induced upregulation of glutamate transporters in astrocytes, Mol Cell Endocrinol, 389, 58, 10.1016/j.mce.2014.01.010 Chakrabarti, 2014, Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration, Brain Res Bull, 109, 22, 10.1016/j.brainresbull.2014.09.004 Adamski, 2004, 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter, Mol Endocrinol, 18, 1963, 10.1210/me.2004-0098 Dimayuga, 2005, Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines, J Neuroimmunol, 161, 123, 10.1016/j.jneuroim.2004.12.016 Polanczyk, 2006, Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway, J Neurosci Res, 84, 370, 10.1002/jnr.20881 Abbott, 2006, Astrocyte-endothelial interactions at the blood-brain barrier, Nat Rev Neurosci, 7, 41, 10.1038/nrn1824 Brand-Schieber, 2005, Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis, J Neurosci Res, 80, 798, 10.1002/jnr.20474 Sinclair, 2007, Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter, Acta Neuropathol, 113, 187, 10.1007/s00401-006-0169-2 Soltani, 2016, Effect of estrogen and/or progesterone administration on traumatic brain injury-caused brain edema: the changes of aquaporin-4 and interleukin-6, J Physiol Biochem, 72, 33, 10.1007/s13105-015-0453-5 Nair, 2008, Astrocytes in multiple sclerosis: a product of their environment, Cell Mol Life Sci, 65, 2702, 10.1007/s00018-008-8059-5 Banks, 2005, Blood-brain barrier transport of cytokines: a mechanism for neuropathology, Curr Pharm Des, 11, 973, 10.2174/1381612053381684 Kang, 2013, Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells, Nat Neurosci, 16, 1401, 10.1038/nn.3505 Kebir, 2007, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, Nat Med, 13, 1173, 10.1038/nm1651 Damsker, 2010, Th1 and Th17 cells: adversaries and collaborators, Ann N Y Acad Sci, 1183, 211, 10.1111/j.1749-6632.2009.05133.x Constantinescu, 1996, Astrocytes and microglia produce interleukin-12 p40, Ann N Y Acad Sci, 795, 328, 10.1111/j.1749-6632.1996.tb52684.x Constantinescu, 2005, Astrocytes as antigen-presenting cells: expression of IL-12/IL-23, J Neurochem, 95, 331, 10.1111/j.1471-4159.2005.03368.x Senecal, 2016, Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses, Glia, 64, 553, 10.1002/glia.22948 Hunter, 2005, New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions, Nat Rev Immunol, 5, 521, 10.1038/nri1648 Aggarwal, 2003, Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17, J Biol Chem, 278, 1910, 10.1074/jbc.M207577200 Becher, 2002, Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12, J Clin Invest, 110, 493, 10.1172/JCI0215751 Gran, 2002, IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination, J Immunol, 169, 7104, 10.4049/jimmunol.169.12.7104 Kostic, 2014, IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis, Scand J Immunol, 79, 181, 10.1111/sji.12147 Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat Immunol, 6, 1123, 10.1038/ni1254 Lee, 2009, Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes, J Neurochem, 110, 530, 10.1111/j.1471-4159.2009.06105.x Pawlak, 2005, Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen, Brain Res Mol Brain Res, 138, 1, 10.1016/j.molbrainres.2004.10.043 Liang, 2002, Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer’s disease patients, J Neurochem, 80, 807, 10.1046/j.0022-3042.2002.00779.x Lee, 2012, Transforming growth factor-alpha mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes, Glia, 60, 1024, 10.1002/glia.22329 Batten, 2006, Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells, Nat Immunol, 7, 929, 10.1038/ni1375 Stumhofer, 2006, Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system, Nat Immunol, 7, 937, 10.1038/ni1376 Stumhofer, 2007, Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10, Nat Immunol, 8, 1363, 10.1038/ni1537